Becker's Healthcare March 25, 2025
Jakob Emerson

GLP-1s are driving traditional drug spending in the U.S. to unprecedented levels, which now outpaces specialty drug spending for the first time, according to a March 25 report from Evernorth.

The report is based on data collected from scientific literature, pharmacy claims, industry reports, and surveys of pharmacists, providers, health plan executives, large employers, and individual consumers. Claims analysis...

Today's Sponsors

Venturous
Got healthcare questions? Just ask Transcarent

Today's Sponsor

Venturous

 
Topics: Biotechnology, Pharma / Biotech, Survey / Study, Trends
Big pharma’s grip on health care: time for change
GLP-1s are accelerating spending growth on traditional drugs, Evernorth research finds
Continuous Process Improvement: The Secret to Navigating Early-Phase Drug Development
Healthy Returns: Novo Nordisk scoops up Chinese obesity drug to compete with Eli Lilly
Character Biosciences raises $93M with an eye on vision loss drugs

Share This Article